Filing Details
- Accession Number:
- 0001140361-15-028594
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-24 16:39:47
- Reporting Period:
- 2015-07-22
- Filing Date:
- 2015-07-24
- Accepted Time:
- 2015-07-24 16:39:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
946486 | Discovery Laboratories Inc | DSCO | Biological Products, (No Disgnostic Substances) (2836) | 943171943 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1301047 | R John Leone | 2600 Kelly Road Suite 100 Warrington PA 18976 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-22 | 50,000 | $0.00 | 79,956 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Warrants (Right to Buy) | Acquisiton | 2015-07-22 | 50,000 | $0.00 | 50,000 | $0.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2015-07-22 | 2022-07-22 | No | 4 | P | Direct |
Footnotes
- Common Stock in connection with the purchase of Series A units acquired in an underwritten public offering of Series A units and Series B units with a unit purchase price of $0.60. Each Series A unit consists of one share of common stock and one Series A warrant to purchase one share of common stock at an initial exercise price of $0.70 per share. Refer to Table II for related Series A warrant information.
- Series A Warrants in connection with the purchase of Series A units acquired in an underwritten public offering of Series A units and Series B units with a unit purchase price of $0.60. Each Series A unit consists of one share of common stock and one Series A warrant to purchase one share of common stock at an initial exercise price of $0.70 per share. Refer to Table I for related common stock information.